Revolax Deep

Revolax Deep with Lidocaine

Revolax Deep with Lidocaine is a monophasic cross-linked hyaluronic acid (HA) dermal filler from Across Co., Ltd., South Korea. It is the medium-firm, highly viscoelastic gel in the Revolax range, designed for injection into the deep dermis or subcutaneous tissue to correct moderate to deep wrinkles and folds and to add volume to the lips, cheeks and chin. It contains 24 mg/ml cross-linked HA and 0.3% lidocaine hydrochloride. Each box contains one 1.1 ml pre-filled syringe. For use by licensed physicians only.

主要特點

• Medium-Firm Gel: Firmer than Revolax Fine and softer than Revolax Sub-Q, intended for deeper placement.
• Monophasic Gel: A uniform, highly viscoelastic cross-linked HA gel, designed for smooth and even injection.
• HA 24 mg/ml:由細菌發酵產生的非動物性透明質酸，與 BDDE 交聯。
• 含0.3%利多卡因：有助於減少注射時的不適感。
• 可逆的: 玻尿酸可以由合格的執業醫師使用玻尿酸酶溶解。

Revolax系列

Revolax系列產品包含三種不同硬度的凝膠。醫生會根據治療部位、組織深度和預期效果選擇合適的產品。

• Revolax Fine: The softest gel, for fine lines in the superficial dermis.
• Revolax Deep: A medium-firm gel for moderate to deep wrinkles and folds and lip volume, in the deep dermis or subcutaneous tissue.
• Revolax Sub-Q: The firmest gel, for deep subcutaneous volume and contour.

預期用途

• Moderate to deep wrinkles and folds
• 法令紋
• Marionette lines
• Lip augmentation
• Cheek and chin augmentation

Treatment area, injection depth, technique and volume must follow the official Instructions for Use and the treating physician’s assessment. Results and duration vary between individuals.

產品規格

• 品牌： Revolax™
• Product: Revolax Deep with Lidocaine
• 製造商： Across Co., Ltd.
• 起源： South Korea
• Composition: Cross-linked hyaluronic acid 24 mg/ml, lidocaine hydrochloride 3 mg/ml (0.3%), phosphate-buffered saline
• Gel Type: Monophasic, BDDE cross-linked
• Injection Depth: Deep dermis or subcutaneous tissue, as specified in the IFU
• Needle: 27G
• Contents: 1 × 1.1 ml pre-filled syringe, 2 × 27G needles
• Shelf Life: Refer to the carton for the expiry date
• 產品類型： Hyaluronic acid dermal filler (medical device)

施用

• For use only by licensed physicians trained in facial anatomy, filler injection techniques and the management of filler complications.
• Inject under aseptic conditions.
• Do not inject into the superficial dermis, as this may cause visible lumps or discoloration.
• Do not inject into the eye area (around the eyes or the eyelids).
• Do not mix with other products before injection.
• Injection depth, technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

預防措施

• Common reactions include redness, swelling, pain, tenderness, itching and bruising at the injection site.
• Lumps, nodules, visible product, discoloration, asymmetry, infection and delayed inflammatory reactions may occur.
• Accidental injection into a blood vessel can cause vascular occlusion, skin necrosis and, rarely, visual impairment or blindness.
• Contains lidocaine. Not suitable for people with known allergy to lidocaine or other amide-type local anaesthetics.
• Do not inject into areas with an existing implant, or with skin inflammation or infection.
• Do not combine in the same session with laser treatment, chemical peels or dermabrasion.
• Hyaluronic acid products are incompatible with quaternary ammonium salts such as benzalkonium chloride.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately for severe or increasing pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is open or damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Do not re-sterilise. Keep out of reach of children.

Who Should Consult a Physician First

• People with known allergy to hyaluronic acid, lidocaine or amide-type local anaesthetics
• Pregnant or breastfeeding women
• People with infection, inflammation or skin disease at the treatment area
• People with bleeding disorders, or who have taken anticoagulants or platelet inhibitors in the previous 2 weeks
• People taking aspirin, NSAIDs or high-dose vitamin C (the IFU recommends avoiding these in the week before injection)
• People with autoimmune disease, a history of keloids or severe allergies
• People with permanent fillers or implants in the treatment area
• People under 18 years of age

After Treatment

As advised in the IFU, avoid make-up for 12 hours after injection and avoid prolonged exposure to sun, UV and extreme temperatures. Follow the treating physician’s aftercare instructions.

貯存

Store at 2–25°C. Protect from direct sunlight and freezing. Refer to the carton for the expiry date.

Package Contents

• 1 × 1.1 ml pre-filled syringe of Revolax Deep with Lidocaine
• 2 × 27G needles
• Instructions for Use

重要通知

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.